NVG-0645

N/A

Report date: 2025/02/10 16:52:43
NME

Base Information

Drug NameNVG-0645
Drug Alias NameEllorarxineNVG-0645DC-645NVG0645
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptors modulators
TargetsRetinoic acid receptors
Therapy Area/IndicationsAmyotrophic Lateral SclerosisParkinson DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNevrargenics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNevrargenics Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisParkinson DiseaseMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A